GT Biopharma to Present at Upcoming September Investor Conferences

BEVERLY HILLS, Calif.: BEVERLY HILLS, Calif., Sept. 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® protein biologic technology platform, announced today that Anthony Cataldo, Chairman & CEO, Dr....

Click to view original post